Header Logo

Connection

STEPHEN PAPPAS to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications STEPHEN PAPPAS has written about Clinical Trials, Phase III as Topic.
STEPHEN PAPPAS
Connection Strength
0.035
Clinical Trials, Phase III as Topic
  1. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017 Jun; 45(11):1390-1402.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.